GNCA
Genocea Biosciences, Inc.
GNCA
GNCA
Delisted
GNCA was delisted on the 2nd of June, 2022.
35 hedge funds and large institutions have $31.1M invested in Genocea Biosciences, Inc. in 2020 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 33 → 35 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
35
Holding in Top 10
1
Calls
$3.35M
Puts
$71K
Top Buyers
| 1 | +$272K | |
| 2 | +$158K | |
| 3 | +$105K | |
| 4 |
BlackRock
New York
|
+$104K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$43.6K |
Top Sellers
| 1 | -$724K | |
| 2 | -$332K | |
| 3 | -$249K | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$188K |
| 5 |
Renaissance Technologies
New York
|
-$87.1K |